18-54224151-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000256429.8(MBD2):āc.409G>Cā(p.Gly137Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000243 in 1,484,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G137V) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000256429.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MBD2 | NM_003927.5 | c.409G>C | p.Gly137Arg | missense_variant | 1/7 | ENST00000256429.8 | NP_003918.1 | |
MBD2 | NM_015832.6 | c.409G>C | p.Gly137Arg | missense_variant | 1/3 | NP_056647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBD2 | ENST00000256429.8 | c.409G>C | p.Gly137Arg | missense_variant | 1/7 | 1 | NM_003927.5 | ENSP00000256429 | P1 | |
MBD2 | ENST00000583046.1 | c.409G>C | p.Gly137Arg | missense_variant | 1/3 | 1 | ENSP00000464554 | |||
MBD2 | ENST00000398398.6 | c.409G>C | p.Gly137Arg | missense_variant | 1/3 | 2 | ENSP00000381435 |
Frequencies
GnomAD3 genomes AF: 0.00000665 AC: 1AN: 150440Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.0000262 AC: 35AN: 1333612Hom.: 0 Cov.: 35 AF XY: 0.0000197 AC XY: 13AN XY: 661120
GnomAD4 genome AF: 0.00000665 AC: 1AN: 150440Hom.: 0 Cov.: 31 AF XY: 0.0000136 AC XY: 1AN XY: 73366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.409G>C (p.G137R) alteration is located in exon 1 (coding exon 1) of the MBD2 gene. This alteration results from a G to C substitution at nucleotide position 409, causing the glycine (G) at amino acid position 137 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at